Marshall Wace
ABVX icon

Marshall Wace’s Abivax ABVX Stock Holding History

Marshall Wace’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,758
Closed -$8.06M – 3132
2025
Q4 		$8.06M Sell
59,758
-129,946
-68% -$14.2M 0.01% 950
2025
Q3 		$16.1M Buy
+189,704
New +$11.6M 0.02% 750
2025
Q2 		– Sell
-74,841
Closed -$468K – 2638
2025
Q1 		$468K Buy
+74,841
New +$507K ﹤0.01% 2107
2024
Q4 		– Sell
-30,910
Closed -$356K – 2532
2024
Q3 		$356K Buy
+30,910
New +$370K ﹤0.01% 2067
2024
Q1 		– Sell
-46,902
Closed -$502K – 2392
2023
Q4 		$502K Buy
+46,902
New +$478K ﹤0.01% 1716

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

Marshall Wace's ABVX Position: Q1 2026 in Review

Marshall Wace sold out of Abivax (ABVX) in Q1 2026, closing a stake of 59,758 shares — an estimated $8.06M sold.

Marshall Wace first reported a position in ABVX in Q4 2023 and held it in 5 quarters. The position peaked at $16.1M in Q3 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Marshall Wace reported no remaining Abivax position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 59,758 Abivax shares in Q1 2026, an estimated $8.06M.
  • Marshall Wace first reported a position in Abivax in Q4 2023 and held it in 5 quarters.
  • Marshall Wace's Abivax position peaked at $16.1M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.